on 18 Jun 2024
Last Applicant/ Owned by
228 Park Ave. South
New York
NY
10003
Serial Number
97978187 filed on 28th Mar 2022
Registration Number
7423563 registered on 18th Jun 2024
Filing Basis
1. intent to use
2. use application currently
Disclaimer
NO DATA
Scientific and technological services, namely, pharmaceutical research and design services relating thereto in the nature of pharmaceutical development; pharmaceutical development services; scientific research in the fields of oncology, aging, longevity, autoimmunity, dysregulated nutrient sensing, overactive cell signaling, the mTOR pathway, and mTOR inhibition; pharmaceutical testing, pre-clinic Read More
Scientific and technological services, namely, pharmaceutical research and design services relating thereto in the nature of pharmaceutical development; pharmaceutical development services; scientific research in the fields of oncology, aging, longevity, autoimmunity, dysregulated nutrient sensing, overactive cell signaling, the mTOR pathway, and mTOR inhibition; pharmaceutical testing, pre-clinical research, and clinical research in the fields of oncology, aging, longevity, autoimmunity, dysregulated nutrient sensing, overactive cell signaling, the mTOR pathway, and mTOR inhibition; medical research; provision of information and consultancy relating to medical and scientific research in the fields of clinical trials, oncology, aging, longevity, autoimmunity, dysregulated nutrient sensing, overactive cell signaling, and the mTOR pathway
16th Feb 2022
16th Feb 2022
No 97978187
No Service Mark
No 0735790
No
No
No
No
No
No
No
No
Status Date | Action Taken |
---|---|
18th Jun 2024 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
18th Jun 2024 | REGISTERED-PRINCIPAL REGISTER |
13th May 2024 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
13th May 2024 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
08th May 2024 | STATEMENT OF USE PROCESSING COMPLETE |
08th May 2024 | DIVISIONAL PROCESSING COMPLETE |
29th Apr 2024 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
08th Apr 2024 | TEAS REQUEST TO DIVIDE RECEIVED |
08th Apr 2024 | USE AMENDMENT FILED |
08th Apr 2024 | TEAS STATEMENT OF USE RECEIVED |